Total Payments
$8,501
2024 Payments
$619.04
Companies
57
Transactions
538
Medicare Patients
2,539
Medicare Billing
$184,789
Payment Breakdown by Category
Food & Beverage$8,130 (95.6%)
Consulting$350.00 (4.1%)
Education$21.72 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,130 | 532 | 95.6% |
| Consulting Fee | $350.00 | 2 | 4.1% |
| Education | $21.72 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,158 | 75 | $0 (2024) |
| GlaxoSmithKline, LLC. | $846.50 | 47 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $751.49 | 48 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $588.75 | 46 | $0 (2024) |
| Astellas Pharma US Inc | $530.67 | 30 | $0 (2024) |
| Lilly USA, LLC | $497.17 | 37 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $461.01 | 20 | $0 (2023) |
| IBSA Pharma Inc. | $401.03 | 20 | $0 (2024) |
| ABBVIE INC. | $384.61 | 30 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $338.03 | 28 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $619.04 | 32 | Novo Nordisk Inc ($132.67) |
| 2023 | $612.69 | 34 | Novo Nordisk Inc ($174.34) |
| 2022 | $1,013 | 72 | Novo Nordisk Inc ($255.76) |
| 2021 | $1,178 | 74 | Novo Nordisk Inc ($252.62) |
| 2020 | $454.81 | 30 | AstraZeneca Pharmaceuticals LP ($72.94) |
| 2019 | $878.08 | 48 | Novartis Pharmaceuticals Corporation ($232.66) |
| 2018 | $1,511 | 106 | Boehringer Ingelheim Pharmaceuticals, Inc. ($199.95) |
| 2017 | $2,235 | 142 | GlaxoSmithKline, LLC. ($451.21) |
All Payment Transactions
538 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $19.90 | General |
| Category: Insulin Pump | ||||||
| 12/13/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $20.51 | General |
| Category: Insulin Pump | ||||||
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $0.97 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: DIABETES | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.33 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $64.13 | General |
| Category: Endocrinology | ||||||
| 09/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: DIABETES | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Biological | ||||||
| 08/23/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $22.63 | General |
| Category: Endocrinology | ||||||
| 08/23/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Obesity | ||||||
| 07/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: DIABETES | ||||||
| 07/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/21/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: ANTI-ANXIETY | ||||||
| 05/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Gastroenterology | ||||||
| 05/03/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Obesity | ||||||
| 04/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Biological | ||||||
| 04/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 693 | 1,009 | $104,914 | $49,342 |
| 2022 | 14 | 646 | 982 | $98,606 | $44,657 |
| 2021 | 10 | 453 | 719 | $91,263 | $43,962 |
| 2020 | 14 | 747 | 1,122 | $102,688 | $46,828 |
Total Patients
2,539
Total Services
3,832
Medicare Billing
$184,789
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 269 | $51,110 | $23,899 | 46.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 93 | 93 | $21,855 | $11,888 | 54.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 55 | $7,700 | $3,493 | 45.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 19 | 22 | $8,140 | $3,351 | 41.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 80 | 80 | $3,160 | $1,421 | 45.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 104 | 137 | $1,370 | $1,151 | 84.0% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 72 | 75 | $3,000 | $1,110 | 37.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 61 | 61 | $2,135 | $1,097 | 51.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 26 | $1,470 | $783.72 | 53.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 56 | $2,464 | $520.76 | 21.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 23 | 23 | $1,150 | $503.70 | 43.8% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 15 | 24 | $480.00 | $92.13 | 19.2% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 16 | 88 | $880.00 | $30.94 | 3.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 278 | $52,820 | $23,570 | 44.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 79 | 79 | $18,565 | $10,449 | 56.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 65 | $9,100 | $3,839 | 42.2% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 11 | 12 | $4,440 | $1,979 | 44.6% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 57 | 57 | $2,240 | $1,046 | 46.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 27 | 27 | $810.00 | $773.82 | 95.5% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 47 | 48 | $1,920 | $753.12 | 39.2% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 28 | 28 | $1,120 | $561.96 | 50.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 26 | 53 | $2,376 | $512.78 | 21.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 112 | 163 | $1,620 | $478.33 | 29.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 19 | 19 | $665.00 | $349.26 | 52.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 22 | 23 | $1,380 | $208.23 | 15.1% |
About Dr. Muhammad Awan, MD
Dr. Muhammad Awan, MD is a Specialist healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518043108.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Awan, MD has received a total of $8,501 in payments from pharmaceutical and medical device companies, with $619.04 received in 2024. These payments were reported across 538 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($8,130).
As a Medicare-enrolled provider, Awan has provided services to 2,539 Medicare beneficiaries, totaling 3,832 services with total Medicare billing of $184,789. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Internal Medicine
- Location Orlando, FL
- Active Since 10/27/2006
- Last Updated 11/22/2016
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1518043108
Products in Payments
- JARDIANCE (Drug) $451.54
- Ozempic (Drug) $432.24
- ENTRESTO (Drug) $419.55
- Rybelsus (Drug) $285.06
- FARXIGA (Drug) $281.39
- BREO (Drug) $240.56
- Tirosint (Drug) $236.99
- MYRBETRIQ (Drug) $204.28
- XARELTO (Drug) $182.01
- Myrbetriq (Drug) $172.45
- UBRELVY (Drug) $170.82
- TRULICITY (Drug) $161.47
- INVOKANA (Drug) $156.02
- SYMBICORT (Drug) $149.37
- NEXLETOL (Drug) $147.77
- Victoza (Drug) $133.95
- SHINGRIX (Biological) $126.87
- JANUVIA (Drug) $125.49
- BEVESPI AEROSPHERE (Drug) $119.38
- ANORO (Drug) $116.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Orlando
Dr. Peter Wearden, Md,Phd, MD,PHD
Specialist — Payments: $60,944
Specialist $60,944
Dr. Anthony Rongione, M.d, M.D
Specialist — Payments: $39,392
Specialist $39,392
Augustine Joseph, Md, MD
Specialist — Payments: $25,257
Specialist $25,257
Michael Anderson, M.d, M.D
Specialist — Payments: $23,459
Specialist $23,459
George Pope, M.d, M.D
Specialist — Payments: $17,863
Specialist $17,863
Dr. Muhammad Jawad, M.d, M.D
Specialist — Payments: $16,793
Specialist $16,793